Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q3IS
|
|||
| Former ID |
DNCL002592
|
|||
| Drug Name |
VB4-845
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42] | Phase 2/3 | [1] | |
| Company |
Viventia Biotechnologies
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tumor-associated calcium signal transducer 1 (EPCAM) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017525) | |||
| REF 2 | A bispecific EpCAM/CD133 targeted toxin is effective against carcinoma. Target Oncol. 2014 September; 9(3): 239-249. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.